Among the 26 patients showing high post-operative blood levels of CD26+/CD326− cells, 18 (69.2%) relapsed, while no tumor recurrence was observed among the 46 patients with normal post-operative blood levels of CD26+/CD326− cells. This evidence concerns the gene DPP4 and neoplasm.